Dr Dal Chun, MD | |
8219 Leesburg Pike, #120, Vienna, VA 22182-2625 | |
(703) 564-4300 | |
(703) 206-7238 |
Full Name | Dr Dal Chun |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 24 Years |
Location | 8219 Leesburg Pike, Vienna, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578587135 | NPI | - | NPPES |
334430400 | Medicaid | MD | |
041273800 | Medicaid | DC | |
1578587135 | Medicaid | VA |
Facility Name | Location | Facility Type |
---|---|---|
Inova Fair Oaks Hospital | Fairfax, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Retina Group Of Washington, Pllc | 5294702692 | 67 |
The Retina Group Of Washington, Pllc | 5294702692 | 67 |
News Archive
New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that often result from HSV-2.
Medicare patients 65 years and older who underwent cataract surgery had a lower odds of hip fracture 1 year after the procedure when compared with patients with cataract who did not have cataract surgery, according to a study in the August 1 issue of JAMA.
Breast cancer is the most common cancer in women worldwide and the second most common cancer overall. Although it can now be treated with drugs, many of these drugs mysteriously stop working after some time, causing a relapse.
Selexis SA, a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins announced today that CSL Limited has entered a commercial license agreement with Selexis for the preclinical development of a therapeutic antibody anticipated to enter Phase I clinical trials in 2012.
› Verified 2 days ago
Entity Name | The Retina Group Of Washington, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225001654 PECOS PAC ID: 5294702692 Enrollment ID: O20040915000226 |
News Archive
New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that often result from HSV-2.
Medicare patients 65 years and older who underwent cataract surgery had a lower odds of hip fracture 1 year after the procedure when compared with patients with cataract who did not have cataract surgery, according to a study in the August 1 issue of JAMA.
Breast cancer is the most common cancer in women worldwide and the second most common cancer overall. Although it can now be treated with drugs, many of these drugs mysteriously stop working after some time, causing a relapse.
Selexis SA, a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins announced today that CSL Limited has entered a commercial license agreement with Selexis for the preclinical development of a therapeutic antibody anticipated to enter Phase I clinical trials in 2012.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Dal Chun, MD 7501 Greenway Center Dr, #300, Greenbelt, MD 20770-3514 Ph: (301) 474-4679 | Dr Dal Chun, MD 8219 Leesburg Pike, #120, Vienna, VA 22182-2625 Ph: (703) 564-4300 |
News Archive
New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that often result from HSV-2.
Medicare patients 65 years and older who underwent cataract surgery had a lower odds of hip fracture 1 year after the procedure when compared with patients with cataract who did not have cataract surgery, according to a study in the August 1 issue of JAMA.
Breast cancer is the most common cancer in women worldwide and the second most common cancer overall. Although it can now be treated with drugs, many of these drugs mysteriously stop working after some time, causing a relapse.
Selexis SA, a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins announced today that CSL Limited has entered a commercial license agreement with Selexis for the preclinical development of a therapeutic antibody anticipated to enter Phase I clinical trials in 2012.
› Verified 2 days ago
Dr. Lisa Framm Sklar, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 302 Maple Ave W, Vienna, VA 22180 Phone: 703-938-1201 Fax: 703-938-3563 | |
Anouche M. Roberts, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 9818 Wintercress Ct, Vienna, VA 22182 Phone: 703-757-0748 | |
Dr. Daniel Herschel Framm, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 302 Maple Ave W, Vienna, VA 22180 Phone: 703-938-1201 Fax: 703-938-3563 | |
Dr. Bella Dave Patnaik, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8150 Leesburg Pike #909, Vienna, VA 22182 Phone: 703-790-1780 Fax: 703-734-0491 | |
Dr. Julie Freidlin Leigh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8150 Leesburg Pike, Suite #909, Vienna, VA 22182 Phone: 703-790-1780 Fax: 703-734-0491 | |
Dr. Jung John Woo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8233 Old Courthouse Rd, Suite 300, Vienna, VA 22182 Phone: 703-917-0012 Fax: 703-917-0028 | |
Dr. Carl J Leto, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8150 Leesburg Pike, Suite 909, Vienna, VA 22182 Phone: 703-790-1780 Fax: 703-734-0491 |